Restoration of DLC1 gene inhibits proliferation and migration of human colon cancer HT29 cells

Annals of Clinical and Laboratory Science

Volumn 39, Issue 3, 2009, Pages 263-269

  Wu, Ping Ping ^a   Jin, Yue Ling ^a   Shang, Yan Fang ^a   Jin, Zhi ^a   Wu, Peng ^a   Huang, Pei Lin ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Apoptosis; Colon cancer; CyclinD1; DLC1 (deleted in liver cancer 1) gene; p21

Indexed keywords

CYCLIN D1; P21 ACTIVATED KINASE;

APOPTOSIS; ARTICLE; CELL CYCLE S PHASE; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN HT29; DISEASE COURSE; DLC1 GENE; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

APOPTOSIS; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION; HT29 CELLS; HUMANS; NEOPLASM INVASIVENESS; TRANSFECTION; TUMOR STEM CELL ASSAY; TUMOR SUPPRESSOR PROTEINS;

EID: 68949130102     PISSN: 00917370     EISSN: 15508080     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Peto J. Cancer epidemiology in the last century and the next decade. Nature 2001;411:390-395. (Pubitemid 32467050)
2. Yuan BZ, Miller MJ, Keck CL, Zimonjic DB, Thorgeirsson SS, Popescu NC. Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Res 1998;58:2196-2199.
3. Lahoz A, Hall A. DLC1: a significant GAP in the cancer genome. Genes Dev 2008;22:1724-1730. (Pubitemid 351915495)
4. Yuan BZ, Durkin ME, Popescu NC. Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene in several common human cancers. Cancer Genet Cytogenet 2003;140:113-117.
5. Ullmannova V, Popescu NC. Expression profile of the tumor suppressor genes DLC-1 and DLC-2 in solid tumors. Int J Oncol 2006;29:1127-1132.
6. Pike BL, Greiner TC, Wang X, Weisenburger DD, Hsu YH, Renaud G, Wolfsberg TG, Kim M, Weisenberger DJ, Siegmund KD, Ye W, Groshen S, Mehrian-Shai R, Delabie J, Chan WC, Laird PW, Hacia JG. DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status. Leukemia 2008;22:1035-1043. (Pubitemid 351689886)
7. Zhou X, Thorgeirsson SS, Popescu NC. Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells. Oncogene 2004;23:1308-1313. (Pubitemid 38297186)
8. Jin Y, Tian X, Shang Y, Huang P. Inhibition of DLC-1 gene expression by RNA interference in the colon cancer LoVo cell line. Oncol Rep 2008;19:669-674. (Pubitemid 351330434)
9. Long DX, Wu YJ. Growth inhibition and induction of G1 phase cell cycle arrest in neuroblastoma SH-SY5Y cell by tri-ortho-cresyl phosphate. Toxicol Lett 2008;181:47-52.
10. Goodison S, Yuan J, Sloan D, Kim R, Li C, Popescu NC, Urquidi V. The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. Cancer Res 2005;65:6042-6053. (Pubitemid 40994388)
11. Song LJ, Ye SL, Wang KF, Weng YQ, Liang CM, Sun RX, Zhao Y, Liu YK, Tang ZY. Relationship between DLC-1 expressions and metastasis in hepatocellular carcinoma. Zhonghua Gan Zang Bing Za Zhi 2005;13:428-431.
12. Kim TY, Lee JW, Kim HP, Jong HS, Kim TY, Jung M, Bang YJ. DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma. Biochem Biophys Res Commun 2007;355:72-77. (Pubitemid 46273368)
13. Guan M, Tripathi V, Zhou X, Popescu NC. Adenovirus-mediated restoration of expression of the tumor suppressor gene DLC1 inhibits the proliferation and tumorigenicity of aggressive, androgen-independent human prostate cancer cell lines: prospects for gene therapy. Cancer Gene Ther 2008;15:371-381. (Pubitemid 351693225)
14. Xue W, Krasnitz A, Lucito R, Sordella R, Vanaelst L, Cordon-Cardo C, Singer S, Kuehnel F, Wigler M, Powers S, Zender L, Lowe SW. DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma. Genes Dev 2008;22:1439-1444. (Pubitemid 351793078)
15. Ullmannova-Benson V, Guan M, Zhou X, Tripathi V, Yang XY, Zimonjic DB, Popescu NC. DLC1 tumor suppressor gene inhibits migration and invasion of multiple myeloma cells through RhoA GTPase pathway. Leukemia 2009;23:383-390.
16. Zhou X, Zimonjic DB, Park SW, Yang XY, Durkin ME, Popescu NC. DLC1 suppresses distant dissemination of human hepatocellular carcinoma cells in nude mice through reduction of RhoA GTPase activity, actin cytoskeletal disruption and down-regulation of genes involved in metastasis. Int J Oncol 2008;32:1285-1291.
17. Rattan R, Giri S, Singh AK, Singh I. Rho/ROCK pathway as a target of tumor therapy. J Neurosci Res 2006;83:243-255. (Pubitemid 43184388)
18. Wong CC, Wong CM, Ko FC, Chan LK, Ching YP, Yam JW, Ng IO. Deleted in liver cancer 1 (DLC1) negatively regulates Rho/ROCK/MLC pathway in hepatocellular carcinoma. PLoS ONE 2008;3:e2779.
19. Gartel AL, Radhakrishnan SK. Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res 2005;65:3980-3985.
20. Radhakrishnan SK, Feliciano CS, Najmabadi F, Haegebarth A, Kandel ES, Tyner AL, Gartel AL. Constitutive expression of E2F-1 leads to p21-dependent cell cycle arrest in S phase of the cell cycle. Oncogene 2004;23:4173-4176. (Pubitemid 38747949)
21. Sahai E, Marshall CJ. Rho-GTPases and cancer. Nat Rev Cancer 2002;2:133-142.
22. Liberto M, Cobrinik D, Minden A. Rho regulates p21, cyclin D1, and checkpoint control in mammary epithelial cells. Oncogene 2002;21:1590-1599. (Pubitemid 34226147)
23. Yi T, Baek JH, Kim HJ, Choi MH, Seo SB, Ryoo HM, Kim GS, Woo KM. Trichostatin A-mediated up-regulation of p21 contributes to osteoclast apoptosis. Exp Mol Med 2007;39:213-221. (Pubitemid 46683407)
24. Zoli W, Ulivi P, Tesei A, Fabbri F, Rosetti M, Maltoni R, Giunchi DC, Ricotti L, Brigliadori G, Vannini I, Amadori D. Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines. Breast Cancer Res 2005;7:R681-R689.
25. Healy KD, Hodgson L, Kim TY, Shutes A, Maddileti S, Juliano RL, Hahn KM, Harden TK, Bang YJ, Der CJ. DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms. Mol Carcinog 2008;47:326-337.
26. Yam JW, Ko FC, Chan CY, Jin DY, Ng IO. Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression. Cancer Res 2006;66:8367-8372.
27. Qian X, Li G, Asmussen HK, Vass WC, Braverman R, Yamada KM, Popescu NC, Papageorge AG, Lowy DR. Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase activating protein activities. PNAS USA 2007;104:9012-9017. (Pubitemid 47175428)
28. Zhong D, Zhang J, Yang S, Soh UJ, Buschdorf JP, Zhou YT, Yang D, Low BC. The SAM domain of the RhoGAP DLC1 binds EF1A1 to regulate cell migration. J Cell Sci 2009;122:414-424.
29. Kawai K, Iwamae Y, Yamaga M, Kiyota M, Ishii H, Hirata H, Homma Y, Yagisawa H. Focal adhesion-localization of START-GAP1/DLC1 is essential for cell motility and morphology. Genes Cells 2009;14:227-241.